diquafosol Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4900 59985-21-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • diquafosol
  • diquafosol sodium
  • diquafosol tetrasodium
  • INS365
purinoceptor P2Y(2) receptor agonist
  • Molecular weight: 790.31
  • Formula: C18H26N4O23P4
  • CLOGP: -5.91
  • LIPINSKI: 3
  • HAC: 27
  • HDO: 10
  • TPSA: 393.55
  • ALOGS: -1.76
  • ROTB: 14

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Feb. 9, 2010 PMDA Santen Pharmaceutical

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

SourceCodeDescription
CHEBI has role CHEBI:53142 p2y2 receptor agonists
CHEBI has role CHEBI:75771 mus musculus metabolite

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Tear film insufficiency indication 46152009

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 1.71 acidic
pKa2 2.32 acidic
pKa3 8.93 acidic
pKa4 9.53 acidic
pKa5 11.46 acidic
pKa6 12.06 acidic
pKa7 13.51 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
P2Y purinoceptor 2 GPCR AGONIST EC50 7.47 SCIENTIFIC LITERATURE SCIENTIFIC LITERATURE
P2Y purinoceptor 4 GPCR AGONIST EC50 6.40 IUPHAR

External reference:

IDSource
D03864 KEGG_DRUG
211427-08-6 SECONDARY_CAS_RN
C1955479 UMLSCUI
CHEBI:27791 CHEBI
CHEMBL221326 ChEMBL_ID
CHEMBL1767408 ChEMBL_ID
DB15919 DRUGBANK_ID
C403315 MESH_SUPPLEMENTAL_RECORD_UI
148197 PUBCHEM_CID
1736 IUPHAR_LIGAND_ID
8326 INN_ID
7828VC80FJ UNII
018489 NDDF
018490 NDDF

Pharmaceutical products:

None